Animal models of Alzheimer disease: historical pitfalls and a path forward
- PMID: 24793844
- DOI: 10.14573/altex.1310071
Animal models of Alzheimer disease: historical pitfalls and a path forward
Abstract
Alzheimer disease (AD) is a medically and financially overwhelming condition, and incidence rates are expected to triple by 2050.Despite decades of research in animal models of AD, the disease remains incompletely understood, with few treatment options. This review summarizes historical and current AD research efforts, with emphasis on the disparity between preclinical animal studies and the reality of human disease and how this has impacted clinical trials. Ultimately, we provide a mechanism for shifting the focus of AD research away from animal models to focus primarily on human biology as a means to improve the applicability of research findings to human disease. Implementation of these alternatives may hasten development of improved strategies to prevent, detect, ameliorate, and possibly cure this devastating disease.
Similar articles
-
Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities.Oncotarget. 2016 Jun 28;7(26):38999-39016. doi: 10.18632/oncotarget.9175. Oncotarget. 2016. PMID: 27229915 Free PMC article.
-
Interview with Dr Peter Whitehouse, 23 July 2012.Dementia (London). 2015 May;14(3):370-82. doi: 10.1177/1471301214562144. Epub 2014 Dec 11. Dementia (London). 2015. PMID: 25502360 No abstract available.
-
Alzheimer's disease: will advances made in the past turn the tide?Ann Pharmacother. 2007 Sep;41(9):1494-6. doi: 10.1345/aph.1K182. Epub 2007 Jul 31. Ann Pharmacother. 2007. PMID: 17666576 No abstract available.
-
Alzheimer's disease drugs: an application of the hormetic dose-response model.Crit Rev Toxicol. 2008;38(5):419-51. doi: 10.1080/10408440802003991. Crit Rev Toxicol. 2008. PMID: 18568864 Review.
-
Alzheimer's disease: clinical features, pathogenesis, and treatment. 1984.Ann Pharmacother. 2007 Sep;41(9):1499-504. doi: 10.1345/aph.140065. Epub 2007 Aug 14. Ann Pharmacother. 2007. PMID: 17698893 Review. No abstract available.
Cited by
-
18F-FDG-PET Detects Drastic Changes in Brain Metabolism in the Tg4-42 Model of Alzheimer's Disease.Front Aging Neurosci. 2019 Jan 8;10:425. doi: 10.3389/fnagi.2018.00425. eCollection 2018. Front Aging Neurosci. 2019. PMID: 30670962 Free PMC article.
-
Peptide regulation of cofilin activity in the CNS: A novel therapeutic approach for treatment of multiple neurological disorders.Pharmacol Ther. 2017 Jul;175:17-27. doi: 10.1016/j.pharmthera.2017.02.031. Epub 2017 Feb 20. Pharmacol Ther. 2017. PMID: 28232023 Free PMC article. Review.
-
Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities.Oncotarget. 2016 Jun 28;7(26):38999-39016. doi: 10.18632/oncotarget.9175. Oncotarget. 2016. PMID: 27229915 Free PMC article.
-
Fingolimod Affects Transcription of Genes Encoding Enzymes of Ceramide Metabolism in Animal Model of Alzheimer's Disease.Mol Neurobiol. 2020 Jun;57(6):2799-2811. doi: 10.1007/s12035-020-01908-3. Epub 2020 Apr 30. Mol Neurobiol. 2020. PMID: 32356173 Free PMC article.
-
Establishment of autaptic culture with human-induced pluripotent stem cell-derived astrocytes.iScience. 2022 Jul 16;25(8):104762. doi: 10.1016/j.isci.2022.104762. eCollection 2022 Aug 19. iScience. 2022. PMID: 35942096 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical